Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05467371 · ClinicalTrials.gov registry record · NA
Safe Babies: Parenting Action Plan ( PAP )
A NA study of Parenting and Motivational Interviewing, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 283
- Enrollment target
- 3
- Study locations
NCT05467371: Completed NA study of Parenting and Motivational Interviewing, sponsored by The University of Texas Health Science Center, Houston.
NCT05467371 is a NA study of Parenting and Motivational Interviewing that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 283 participants, below the 644-participant average among 66 other Parenting trials with a reported enrollment target (56% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05467371, a NA study of Parenting and Motivational Interviewing, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 283 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal is to examine the efficacy of the Parenting Action Plan (PAP), a booklet with information that focuses on sleep hygiene, soothing a crying baby, what to do when the baby's crying is overwhelming, identifying safe caregivers in case of emergency, and issues surrounding feeding and bonding with the baby.
Primary Outcome
The Parent Attribution Test will be used to assess maltreatment risk. This survey was chosen because it has been shown to be predictive of maltreatment in high risk families27. Further, this survey is relatively immune to social desirability bias28, partially because it does not specifically ask parents about their own parenting practices.
Conditions Studied
Interventions
- BEHAVIORAL Parenting Action Plan
- BEHAVIORAL Safe Kids Home Safety Checklist
Study Locations (3)
Texas
- Baylor College of Medicine - Houston
- The University of Texas Health Science Center at Houston - Houston
- University of Texas Health Science Center at Tyler - Tyler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 283 participants |
| Start Date | 2022-08-23 |
| Est. Completion | 2025-06-15 |
| Phase | NA |
What the finished NCT05467371 record still lists
NCT05467371 is an interventional study that assigns participants to a tested intervention. The registered 283 participants enrollment target is mid-sized for trials with a published cap, below the 644-participant average among 66 other Parenting trials with a reported enrollment target (56% lower).
The record links to 3 conditions, with Parenting appearing as the primary indexed condition, and to 2 interventions - of which Parenting Action Plan is the first listed.
NCT05467371 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05467371 about?
NCT05467371 is a clinical study titled "Safe Babies: Parenting Action Plan ( PAP )". The goal is to examine the efficacy of the Parenting Action Plan (PAP), a booklet with information that focuses on sleep hygiene, soothing a crying baby, what to do when the baby's crying is overwhelming, identifying safe caregivers in case of emergency, and issues surrounding feeding and bonding wi...
What is the current status of trial NCT05467371?
This trial is currently completed. It is a NA study. The enrollment target is 283 participants. The study started on 2022-08-23. Estimated completion is 2025-06-15.
What conditions does trial NCT05467371 study?
This clinical trial studies the following conditions: Parenting, Motivational Interviewing, Maltreatment/Abuse.
What interventions are being tested in trial NCT05467371?
The interventions under investigation include: Parenting Action Plan (BEHAVIORAL), Safe Kids Home Safety Checklist (BEHAVIORAL).
Who is sponsoring clinical trial NCT05467371?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05467371 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parenting
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05467371's enrollment target sits among peer trials
283 27th of 66 higher than 40 of 66 other Parenting trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parenting trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Chicago Parent Program for Foster and Kinship Caregivers
RECRUITING · NA
-
Parent Intervention for Psychiatrically-Hospitalized Youth
RECRUITING · NA
-
Evaluation of the Parenting in the Moment Online Program for Forcibly Displaced Families
RECRUITING · NA
-
Pilot Trial of the RUBI Program for Autistic Adults
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
-
I-InTERACT Preterm Parenting
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06856694 · 283 participants · NA
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI